Advertisement

Topics

Lundbeck reveals Alzheimer’s drug trial failure

06:09 EDT 23 Sep 2016 | PharmaTimes

Lundbeck has announced that the first late-stage trial of its experimental Alzheimer's disease candidate idalopirdine failed to hit its primary targets.

Original Article: Lundbeck reveals Alzheimer’s drug trial failure

NEXT ARTICLE

More From BioPortfolio on "Lundbeck reveals Alzheimer’s drug trial failure"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...